Grown Rogue International (GRUSF) Profit After Tax Growth (5y) (2014 - 2023)
Grown Rogue International (GRUSF) Profit After Tax Growth (5y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 36.86% |
| Jul 31, 2023 | 20.29% |
| Apr 30, 2023 | -17.79% |
| Jan 31, 2023 | -15.02% |
| Aug 31, 2018 | -50.17% |
| May 31, 2018 | 23.47% |
| Feb 28, 2018 | 23.09% |
| Nov 30, 2017 | 19.76% |
| Aug 31, 2017 | -36.02% |
| May 31, 2017 | -17.37% |
| Feb 28, 2017 | 20.26% |
| Nov 30, 2016 | -0.82% |
| Aug 31, 2016 | 18.36% |
| May 31, 2016 | -44.41% |
| Feb 29, 2016 | -84.90% |
| Nov 30, 2015 | 168.76% |
| Aug 31, 2015 | 42.01% |
| May 31, 2015 | -130.11% |
| Feb 28, 2015 | 43.70% |
| Nov 30, 2014 | -51.69% |